In an update to stock ratings, analyst Louis Navellier has revised recommendations for 95 blue-chip stocks as of October 2023. Key upgrades included ConocoPhillips (COP), Cisco Systems (CSCO), and CVS Health (CVS), each receiving an “A” grade for overall performance. Pfizer (PFE) and other companies such as Booking Holdings (BKNG) and Nike (NKE) were downgraded, with Pfizer moving to a “C” grade.
The revisions were driven by analysis of institutional buying pressure and each company’s fundamental health. Investors are encouraged to review their portfolios based on these newly published ratings to identify potential investment opportunities.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
